InforSense and febit Announce OEM for Geniom Platform
News Jun 08, 2009
InforSense Ltd. has announced that febit has integrated key components of the InforSense platform to provide the data analysis and visualization functionality in febit’s new Geniom flexible microarray platform. febit has embedded the InforSense platform, workflows and visualizations and delivers them to customers with each Geniom instrument.
The InforSense platform provides rich data analytics and rapid application development capabilities. InforSense’s VisualSense offers sophisticated, interactive web based visualization of scientific data. The Geniom platform from febit delivers a completely configurable microarray environment as well as a growing portfolio of catalogue biochips.
Key applications include targeted sequence capture prior to Next Generation Sequencing (NGS), as well as classical transcriptomic applications. When used together InforSense and febit enable a wide range of pharmaceutical and medical research customers to more effectively analyze and view their data to improve disease understanding.
“Geniom’s microarrays are completely configurable if needed, requiring very flexible tools for quality control tests, experimental design, data analysis, and visualization,” said Anthony Caruso, VP of Global Informatics at febit.http://www.febit.com
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.